Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

106 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Toxicity of Radiosurgery for Brainstem Metastases.
Patel A, Dong T, Ansari S, Cohen-Gadol A, Watson GA, Moraes FY, Nakamura M, Murovic J, Chang SD, Hatiboglu MA, Chung C, Miller JC, Lautenschlaeger T. Patel A, et al. Among authors: watson ga. World Neurosurg. 2018 Nov;119:e757-e764. doi: 10.1016/j.wneu.2018.07.263. Epub 2018 Aug 8. World Neurosurg. 2018. PMID: 30096494 Free article. Review.
Histology, Tumor Volume, and Radiation Dose Predict Outcomes in NSCLC Patients After Stereotactic Ablative Radiotherapy.
Shiue K, Cerra-Franco A, Shapiro R, Estabrook N, Mannina EM, Deig CR, Althouse S, Liu S, Wan J, Zang Y, Agrawal N, Ioannides P, Liu Y, Zhang C, DesRosiers C, Bartlett G, Ewing M, Langer MP, Watson G, Zellars R, Kong FM, Lautenschlaeger T. Shiue K, et al. J Thorac Oncol. 2018 Oct;13(10):1549-1559. doi: 10.1016/j.jtho.2018.06.007. Epub 2018 Jun 27. J Thorac Oncol. 2018. PMID: 29959060 Free PMC article.
Efficacy of pre-operative stereotactic radiosurgery followed by surgical resection and correlative radiobiological analysis for patients with 1-4 brain metastases: study protocol for a phase II trial.
Huff WX, Agrawal N, Shapiro S, Miller J, Kulwin C, Shah M, Savage JJ, Payner T, Vortmeyer A, Watson G, Dey M. Huff WX, et al. Radiat Oncol. 2018 Dec 20;13(1):252. doi: 10.1186/s13014-018-1178-8. Radiat Oncol. 2018. PMID: 30572923 Free PMC article. Clinical Trial.
Radiosurgery dose reduction for brain metastases on immunotherapy (RADREMI): A prospective phase I study protocol.
McClelland S 3rd, Lautenschlaeger T, Zang Y, Hanna NH, Shiue K, Kamer AP, Agrawal N, Ellsworth SG, Rhome RM, Watson GA. McClelland S 3rd, et al. Among authors: watson ga. Rep Pract Oncol Radiother. 2020 Jul-Aug;25(4):500-506. doi: 10.1016/j.rpor.2020.04.007. Epub 2020 Apr 23. Rep Pract Oncol Radiother. 2020. PMID: 32477016 Free PMC article. Review.
Isocitrate dehydrogenase 1 mutant glioblastomas demonstrate a decreased rate of pseudoprogression: a multi-institutional experience.
Mohammadi H, Shiue K, Grass GD, Verma V, Engellandt K, Daubner D, Schackert G, Gondim MJ, Gondim D, Vortmeyer AO, Kamer AP, Jin W, Robinson TJ, Watson G, Yu HM, Lautenschlaeger T. Mohammadi H, et al. Neurooncol Pract. 2020 Mar;7(2):185-195. doi: 10.1093/nop/npz050. Epub 2019 Oct 10. Neurooncol Pract. 2020. PMID: 32626587 Free PMC article.
Baseline Karnofsky performance status is independently predictive of death within 30 days of intracranial radiation therapy completion for metastatic disease.
McClelland Iii S, Agrawal N, Elbanna MF, Shiue K, Bartlett GK, Lautenschlaeger T, Zellars RC, Watson GA, Ellsworth SG. McClelland Iii S, et al. Among authors: watson ga. Rep Pract Oncol Radiother. 2020 Jul-Aug;25(4):698-700. doi: 10.1016/j.rpor.2020.02.014. Epub 2020 Feb 24. Rep Pract Oncol Radiother. 2020. PMID: 32684855 Free PMC article.
Risk factors for symptomatic radiation pneumonitis after stereotactic body radiation therapy (SBRT) in patients with non-small cell lung cancer.
Liu Y, Wang W, Shiue K, Yao H, Cerra-Franco A, Shapiro RH, Huang KC, Vile D, Langer M, Watson G, Bartlett G, Ai H, Sheski F, Jin JY, Zellars R, Fu P, Lautenschlaeger T, Kong FS. Liu Y, et al. Radiother Oncol. 2021 Mar;156:231-238. doi: 10.1016/j.radonc.2020.10.015. Epub 2020 Oct 21. Radiother Oncol. 2021. PMID: 33096168
106 results